[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353383-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353383-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","risk-stratification-in-locally-invasive-pancreatic-serous-cystic-neoplasms-systematic-review-and-two-cases","Risk stratification in locally invasive pancreatic serous cystic neoplasms - systematic review and two cases","","Current diagnostic criteria for pancreatic serous cystadenocarcinoma create a grey zone for locally invasive, non-metastatic tumours. A combined cohort of 25 patients was compiled from a systematic literature review and two additional institutional cases. Infiltrative growth was near-universal (23/25), with frequent local invasion into adjacent organs (40%). Metachronous distant metastases developed in 28% (median 40.5 months), and Ki-67 hotspots showed markedly elevated indices (5% and 10%) versus conventional serous cystadenomas (\u003C2%).",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/risk-stratification-in-locally-invasive-pancreatic-serous-cystic-neoplasms-systematic-review-and-two-cases/353383/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/risk-stratification-in-locally-invasive-pancreatic-serous-cystic-neoplasms-systematic-review-and-two-cases/353383.png","ImageObject",300,407,{"name":42,"@type":43},"mieayamfan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What clinical diagnostic grey zone does the study address?","Question",{"text":63,"@type":64},"Locally invasive pancreatic serous cystadenocarcinoma cases that have not yet developed distant metastasis at presentation fall into a diagnostic grey zone under existing criteria.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients included in the analysis?",{"text":68,"@type":64},"A combined cohort of 25 patients was assembled from a systematic literature review and supplemented with two institutional consultation cases.",{"name":70,"@type":61,"acceptedAnswer":71},"Which findings indicate higher malignant potential in locally invasive serous neoplasms?",{"text":72,"@type":64},"Near-universal infiltrative growth, frequent local invasion into adjacent organs, subsequent metachronous distant metastases, and elevated Ki-67 proliferation indices in hotspot areas support a high-risk subgroup.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353383,1790740698,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Original research  \nRisk stratification in locally invasive pancreatic serous cystic neoplasms: systematic review and two cases  \nCong Tan  , 1,2 Xinyi Chen, 1,2 Shu-juan Ni  , 1,2 Meng Zhang, 1,2 Xu Cai, 1,2 Wenhua Jiang, 1,2 Weiqi Sheng, 1,2 Dan Huang 1,2  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.1136/jcp-2025-210480](10.1136/jcp-2025-210480)) .  \n1Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China  \nCorrespondence to  \nDr Dan Huang; danhuang@ [shca.org.cn](shca.org.cn)  \nCT and XC are joint first authors.  \nReceived 28 October 2025 Accepted 25 April 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nTo cite: Tan C, Chen X, Ni S, et al. J Clin Pathol Epub ahead of print: [please include Day Month Year] . doi:10 . 1136/jcp-2025- 210480  \nABSTRACT  \nAims Current diagnostic criteria for pancreatic serous cystadenocarcinoma (SCC) create a grey zone for tumours that are locally invasive but not yet metastatic. We sought to resolve this ambiguity by defining the clinicopathological features and searching for the malignant potential of this aggressive subset of serous neoplasms.  \nMethods A combined cohort of 25 patients was compiled from a systematic literature review and augmented with two institutional cases.  \nResults Infiltrative growth was a near-universal finding (23/25), often in tumours with a prominent solid architecture. This growth pattern was reflected by frequent local invasion into adjacent organs (40%) . The malignant potential of these neoplasms was confirmed by the development of metachronous distant metastases in 28% of patients (median time:  \n40.5 months) despite their absence at presentation. Our institutional cases highlight the diagnostic value of Ki-67 immunohistochemistry, revealing markedly elevated proliferation indices (5% and 10% in hotspots) that starkly contrast with those of conventional serous cystadenomas (\u003C2%) .  \nConclusion Local invasion in serous neoplasms, especially when combined with a solid architecture and high Ki-67 index, defines a high-risk subset highly suspicious for serous cystadenocarcinoma. This interpretation must be balanced against the generally indolent behaviour of most serous neoplasms, and such cases warrant closer clinical surveillance.  \nINTRODUCTION  \nPancreatic serous neoplasms (PSNs) are a distinctive group of cystic lesions, the vast majority of which are benign serous cystadenomas (SCAs), defined by an indolent clinical course and excellent prognosis.1 2 This prevailing view of PSNs as almost uniformly benign entities has historically supported a conservative management approach. However, this benign spectrum harbours an exceedingly rare and lethal counterpart: the serous cystadenocarcinoma (SCC). The existence of this malignant subtype not only challenges established dogma but also presents a formidable diagnostic challenge.3 4 This complexity is highlighted in the 5th Edition of the WHO Classification of Digestive System Tumours, which reserves the diagnosis of SCC to be restricted to cases with documented distant metastasis.5 Consequently, tumours that exhibit only local invasion, such as infiltration into adjacent organs or major vasculature, occupy a controversial nosologic  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n\n| ⇒ Current diagnostic criteria for pancreatic serous cystadenocarcinoma are limited and create a recognised grey zone for serous neoplasms that show local invasion but lack distant metastasis at presentation.\u003Cbr>WHAT THIS STUDY ADDS |\n| --- |\n| ⇒ This systematic review summarises 23 published cases of locally invasive pancreatic serous neoplasms reported without synchronous distant metastasis and documents that ","cbCaijTTXd9kuFjj","https://ap.wps.com/l/cbCaijTTXd9kuFjj","pdf",2109542,"English","# ABSTRACT\n# INTRODUCTION\n# WHAT IS ALREADY KNOWN ON THIS TOPIC\n# WHAT THIS STUDY ADDS\n# HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY","[{\"question\":\"What clinical diagnostic grey zone does the study address?\",\"answer\":\"Locally invasive pancreatic serous cystadenocarcinoma cases that have not yet developed distant metastasis at presentation fall into a diagnostic grey zone under existing criteria.\"},{\"question\":\"How were patients included in the analysis?\",\"answer\":\"A combined cohort of 25 patients was assembled from a systematic literature review and supplemented with two institutional consultation cases.\"},{\"question\":\"Which findings indicate higher malignant potential in locally invasive serous neoplasms?\",\"answer\":\"Near-universal infiltrative growth, frequent local invasion into adjacent organs, subsequent metachronous distant metastases, and elevated Ki-67 proliferation indices in hotspot areas support a high-risk subgroup.\"}]","Risk stratification in locally invasive pancreatic serous cystic neoplasms - systematic review and two cases | PDF",1790105031,18,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1819659d1bb632a542e75ac59cf0a443.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/287983c2f65f653a15e2c09bb135b77a.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/724b708b2070794a965c419ef4af2c80.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c291bf6fa7eba9011ce6f5a9ef78c13.webp",980,1306]